134 related articles for article (PubMed ID: 9357016)
1. Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42).
Akiyama H; Mori H; Sahara N; Kondo H; Ikeda K; Nishimura T; Oda T; McGeer PL
Neurochem Res; 1997 Dec; 22(12):1499-506. PubMed ID: 9357016
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease.
Akiyama H; Mori H; Saido T; Kondo H; Ikeda K; McGeer PL
Glia; 1999 Feb; 25(4):324-31. PubMed ID: 10028915
[TBL] [Abstract][Full Text] [Related]
3. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
[TBL] [Abstract][Full Text] [Related]
4. The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease.
Behrouz N; Defossez A; Delacourte A; Mazzuca M
J Gerontol; 1991 Nov; 46(6):B209-12. PubMed ID: 1719062
[TBL] [Abstract][Full Text] [Related]
5. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
6. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).
Iwatsubo T; Odaka A; Suzuki N; Mizusawa H; Nukina N; Ihara Y
Neuron; 1994 Jul; 13(1):45-53. PubMed ID: 8043280
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
8. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
Coria F; Castaño EM; Frangione B
Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
10. Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains.
Tekirian TL; Cole GM; Russell MJ; Yang F; Wekstein DR; Patel E; Snowdon DA; Markesbery WR; Geddes JW
Neurobiol Aging; 1996; 17(2):249-57. PubMed ID: 8744406
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
Mann DM; Jones D; Prinja D; Purkiss MS
Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
[TBL] [Abstract][Full Text] [Related]
13. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2001 Jan; 60(1):94-104. PubMed ID: 11202179
[TBL] [Abstract][Full Text] [Related]
14. Columnar arrangement of beta-amyloid protein deposits in the cerebral cortex of patients with Alzheimer's disease.
Akiyama H; Yamada T; McGeer PL; Kawamata T; Tooyama I; Ishii T
Acta Neuropathol; 1993; 85(4):400-3. PubMed ID: 8480513
[TBL] [Abstract][Full Text] [Related]
15. The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals.
Coria F; Moreno A; Rubio I; García MA; Morato E; Mayor F
Neuropathol Appl Neurobiol; 1993 Jun; 19(3):261-8. PubMed ID: 8355812
[TBL] [Abstract][Full Text] [Related]
16. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
17. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
Savage MJ; Iqbal M; Loh T; Trusko SP; Scott R; Siman R
Neuroscience; 1994 Jun; 60(3):607-19. PubMed ID: 7936190
[TBL] [Abstract][Full Text] [Related]
19. Early amyloid-beta deposits show different immunoreactivity to the amino- and carboxy-terminal regions of beta-peptide in Alzheimer's disease and Down's syndrome brain.
Kida E; Wisniewski KE; Wisniewski HM
Neurosci Lett; 1995 Jun; 193(2):105-8. PubMed ID: 7478152
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
